ALYMSYS
Active substance: bevacizumab-maly
INJECTION, SOLUTION · BEVACIZUMAB-MALY 400 mg/16mL
United StatesActive
Marketing holder: Valorum Biologics, LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
Composition
- BEVACIZUMAB-MALY · 400 mg/16mL
Registration
- Registration number
- 85006-1755
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 85006-1755 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 85006-1755 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 85006-1755 · Verified 2026-10-09 · open in source